The ongoing price war in the intraoral scanner (IOS) market is not a simple black-and-white issue. It is a complex game that delivers short-term inclusive benefits while carrying long-term risks. In the near term, lower prices accelerate digital adoption, support domestic brands, and lower the barrier for clinics. However, if disorderly low-price competition continues, it can squeeze R&D and after-sales resources, leading to compromises in accuracy and homogenization - potentially creating a "bad money drives out good" scenario.
01. The Inclusive Value of the Price War
Accelerating digital penetration Entry-level intraoral scanners have dropped into the 10,000–20,000 RMB range, enabling county-level clinics, community practices, and smaller institutions to adopt digital workflows at low cost. Penetration in third- and fourth-tier cities is rising rapidly. Domestic devices priced 40–50% lower than imported brands force international players to adjust prices, expanding the overall market so more patients can experience comfortable, efficient scanning.
Speeding up domestic substitution After the pandemic, strong global demand combined with competitive pricing helped Chinese brands quickly capture significant market share (around 45% in some reports). Many have progressed from basic low-end alternatives to closing the technology gap. Price competition has become a "door-opener" for building market trust and accelerating a domestic technology ecosystem.
Helping clinics transition to digital Lower equipment costs make it easier for practices to set up chairside digital systems. This shortens impression and restoration cycles and reduces patient visits. For budget-conscious clinics, affordable scanners serve as an entry point to accumulate digital experience and prepare for future upgrades.
02. Potential Risks of the Price War
Squeezing investment in R&D and after-sales support Fierce price competition severely compresses manufacturers' profit margins. This can leave little room for long-term innovation or professional technical support and training for clinics. Technology iteration may slow as a result.
Concerns over data quality and accuracy Some ultra-low-priced products may compromise on core performance metrics such as precision, repeatability, and marginal fit. Scan data forms the foundation of all subsequent treatment. Inaccurate data can lead to ill-fitting restorations, deviations in surgical guides, or flawed orthodontic plans - ultimately harming patients and damaging clinicians' reputations. This is the most dangerous aspect of "bad money."
Parameter exaggeration and experience pitfalls Certain brands advertise high resolution and speed, yet real-world use reveals lag, frame drops, or difficulty scanning posterior areas. Clinics that only compare price and paper specifications risk choosing poorly performing devices.
03. Will the Market See Long-Term "Bad Money Driving Out Good"?
"Good money" is redefining itself Leading brands - both international and domestic - now build competitive moats far beyond hardware. These include:
Deep, stable software ecosystems and seamless integration with CAD/CAM design software, implant planning platforms, and clear-aligner systems
Data value and AI capabilities (AI-assisted diagnosis and design based on large scan datasets)
Brand trust backed by long-term clinical validation across complex cases
Global service and support networks
Clinic awareness is upgrading Experienced practice managers understand that total cost of ownership matters more than purchase price. A cheap but inaccurate, unreliable, or poorly supported scanner generates remakes, patient complaints, and lost opportunity costs that far exceed any initial savings. Many are willing to pay a premium for certainty, efficiency, and peace of mind.
Clearer market segmentation is emerging
High-end or specialty clinics focused on maximum efficiency and results continue to choose premium brands for top technology and ecosystems.
General and private practices seek the best balance of accuracy, speed, price, and service - the true "value-for-money" leaders.
Extremely budget-limited or specific-use scenarios may still use entry-level devices as supplements or trial tools.
Conclusion: A Necessary Shakeout Toward Healthy Inclusion
The intraoral scanner price war is an inevitable growing pain as the industry moves from technology monopoly to mass adoption. It begins with strong inclusive benefits but is accompanied by disturbances from lower-quality offerings. This will not end with "bad money" winning. Instead, it will act as a market filter.
Products that rely solely on low prices while compromising core medical data quality will be eliminated by professional judgment and clinical results. Brands that maintain data accuracy, open ecosystems, and reliable service under reasonable cost control will emerge as the new "good money." Only these players can deliver genuine, sustainable digital inclusion for the dental industry.
Choose reliability without compromise. Aident Technology's AI-30 Intraoral Scanner delivers true 10 μm accuracy, powder-free true-color scanning, ultra-lightweight design (156 g), anti-fog heating, and full open-system compatibility with major CAD platforms such as exocad. Combined with strong after-sales support and proven clinical performance, it represents the balanced, high-value choice for clinics seeking both accessibility and professional-grade results.
Explore our Intraoral Scanners and complete Digital Dentistry Solutions.
Request a quote today and experience the difference of a scanner built for long-term clinical success.
